As patients challenge patent, J&J commits to tackling drug-resistant TB - e NEWS

Monday, February 18, 2019

Home business Business Line - Home As patients challenge patent, J&J commits to tackling drug-resistant TB

As patients challenge patent, J&J commits to tackling drug-resistant TB

e NEWS 12:01 AM business, Business Line - Home,

While Bedaquiline patent is contested, firm denies its monopoly would get extended

from Business Line - Home http://bit.ly/2Iiew5J
via IFTTT

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Crafted with by Templatesyard | Distributed by Blogspot